Literature DB >> 18040898

Optimization of the AT-content of codons immediately downstream of the initiation codon and evaluation of culture conditions for high-level expression of recombinant human G-CSF in Escherichia coli.

Dasari V Krishna Rao1, Joginapally V Rao, Mangamoori L Narasu, Adibhatla Kali S Bhujanga Rao.   

Abstract

Enhanced therapeutic importance of recombinant human granulocyte colony stimulating factor (rhG-CSF) has encouraged us to develop a processing method for its high-level expression in E. coli. In this study, we established a high-yielding clone by incorporation of silent mutations at N-terminal region of human G-CSF gene. We studied and optimized various parameters of culture conditions connected with the expression of rhG-CSF. The maximum expression was obtained in a defined medium supplemented with 1% glucose. The gene in pET-3a vector in E. coli BL21 (DE3) PLysS host strain was induced with 2 mM isopropyl beta-D: -1-thiogalacto pyronoside. The cell growth and productivity was enhanced about 1.6- and 1.5-folds, respectively when inducing the culture at OD(600) value of 6 than 2. The protein expression was significantly increased by addition of rifampicin at concentration of 200 microg/ml. The AT content of 51.8% with suitable codon sequences at N-terminal region and the concentration of rifampicin were identified as the key factors with a significant impact on protein expression. The specific productivity of 104 mg/OD/l (68.7% of total cellular protein) of rhG-CSF was obtained toward the end of the study, which is almost 1.5 times higher yield than reported so far in the literature.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18040898     DOI: 10.1007/s12033-007-9018-3

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  35 in total

1.  Reduced background expression and improved plasmid stability with pET vectors in BL21 (DE3).

Authors:  S H Pan; B A Malcolm
Journal:  Biotechniques       Date:  2000-12       Impact factor: 1.993

2.  Overexpression and purification of recombinant human interferon alpha2b in Escherichia coli.

Authors:  Poonam Srivastava; Palash Bhattacharaya; Gaurav Pandey; K J Mukherjee
Journal:  Protein Expr Purif       Date:  2005-06       Impact factor: 1.650

3.  mRNA secondary structure in an open reading frame reduces translation efficiency in Bacillus subtilis.

Authors:  M Kubo; T Imanaka
Journal:  J Bacteriol       Date:  1989-07       Impact factor: 3.490

4.  Protein misfolding and inclusion body formation in recombinant Escherichia coli cells overexpressing Heat-shock proteins.

Authors:  J G Thomas; F Baneyx
Journal:  J Biol Chem       Date:  1996-05-10       Impact factor: 5.157

5.  Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.

Authors:  H Teshima; J Ishikawa; H Kitayama; T Yamagami; A Hiraoka; H Nakamura; H Shibata; T Masaoka; F Takaku
Journal:  Exp Hematol       Date:  1989-09       Impact factor: 3.084

6.  Codon optimization of the gene encoding a domain from human type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli.

Authors:  R S Hale; G Thompson
Journal:  Protein Expr Purif       Date:  1998-03       Impact factor: 1.650

7.  Specific replacement of consecutive AGG codons results in high-level expression of human cardiac troponin T in Escherichia coli.

Authors:  X Hu; Q Shi; T Yang; G Jackowski
Journal:  Protein Expr Purif       Date:  1996-05       Impact factor: 1.650

8.  Genomic analysis of high-cell-density recombinant Escherichia coli fermentation and "cell conditioning" for improved recombinant protein yield.

Authors:  R T Gill; M P DeLisa; J J Valdes; W E Bentley
Journal:  Biotechnol Bioeng       Date:  2001-01-05       Impact factor: 4.530

9.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

10.  Alteration of amino-terminal codons of human granulocyte-colony-stimulating factor increases expression levels and allows efficient processing by methionine aminopeptidase in Escherichia coli.

Authors:  P E Devlin; R J Drummond; P Toy; D F Mark; K W Watt; J J Devlin
Journal:  Gene       Date:  1988-05-15       Impact factor: 3.688

View more
  7 in total

1.  Impact of dissolved oxygen concentration on some key parameters and production of rhG-CSF in batch fermentation.

Authors:  Dasari V Krishna Rao; Chatadi T Ramu; Joginapally V Rao; Mangamoori L Narasu; Adibhatla Kali S Bhujanga Rao
Journal:  J Ind Microbiol Biotechnol       Date:  2008-06-03       Impact factor: 3.346

2.  Multiparameter RNA and codon optimization: a standardized tool to assess and enhance autologous mammalian gene expression.

Authors:  Stephan Fath; Asli Petra Bauer; Michael Liss; Anne Spriestersbach; Barbara Maertens; Peter Hahn; Christine Ludwig; Frank Schäfer; Marcus Graf; Ralf Wagner
Journal:  PLoS One       Date:  2011-03-03       Impact factor: 3.240

3.  Gene optimization mechanisms: a multi-gene study reveals a high success rate of full-length human proteins expressed in Escherichia coli.

Authors:  Barbara Maertens; Anne Spriestersbach; Uritza von Groll; Udo Roth; Jan Kubicek; Michael Gerrits; Marcus Graf; Michael Liss; Daniela Daubert; Ralf Wagner; Frank Schäfer
Journal:  Protein Sci       Date:  2010-07       Impact factor: 6.725

4.  Expression of the functional recombinant human glycosyltransferase GalNAcT2 in Escherichia coli.

Authors:  Jennifer Lauber; René Handrick; Sebastian Leptihn; Peter Dürre; Sabine Gaisser
Journal:  Microb Cell Fact       Date:  2015-01-13       Impact factor: 5.328

Review 5.  High-throughput recombinant protein expression in Escherichia coli: current status and future perspectives.

Authors:  Baolei Jia; Che Ok Jeon
Journal:  Open Biol       Date:  2016-08       Impact factor: 6.411

6.  Simplified large-scale refolding, purification, and characterization of recombinant human granulocyte-colony stimulating factor in Escherichia coli.

Authors:  Chang Kyu Kim; Chi Ho Lee; Seung-Bae Lee; Jae-Wook Oh
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

7.  High level in vivo mucin-type glycosylation in Escherichia coli.

Authors:  Phillipp Mueller; Rahul Gauttam; Nadja Raab; René Handrick; Claudia Wahl; Sebastian Leptihn; Michael Zorn; Michaela Kussmaul; Marianne Scheffold; Bernhard Eikmanns; Lothar Elling; Sabine Gaisser
Journal:  Microb Cell Fact       Date:  2018-10-26       Impact factor: 5.328

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.